BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 23382657)

  • 1. Getting more generous with the truth: clinical trial reporting in 2013 and beyond.
    Barbour V; Clark J; Connell L; Ross A; Simpson P; Veitch E; Winker M
    PLoS Med; 2013; 10(1):e1001379. PubMed ID: 23382657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GSK is accused of trying to suppress editorial on rosiglitazone.
    Tanne JH
    BMJ; 2010 May; 340():c2654. PubMed ID: 20484354
    [No Abstract]   [Full Text] [Related]  

  • 3. Full disclosure.
    Maxwell D
    Can Fam Physician; 2008 Oct; 54(10):1377-8; discussion 1378. PubMed ID: 18854458
    [No Abstract]   [Full Text] [Related]  

  • 4. In reply.
    Schott G; Pachl H; Ludwig WD; Dünnweber C; Mühlbauer B; Niebling W
    Dtsch Arztebl Int; 2014 Jan; 111(3):37-8. PubMed ID: 24606786
    [No Abstract]   [Full Text] [Related]  

  • 5. Transparency is key.
    Follmann M
    Dtsch Arztebl Int; 2014 Jan; 111(3):37. PubMed ID: 24606785
    [No Abstract]   [Full Text] [Related]  

  • 6. Manipulated evidence?
    Strömer K; Reusch M
    Dtsch Arztebl Int; 2014 Jan; 111(3):36-7. PubMed ID: 24606784
    [No Abstract]   [Full Text] [Related]  

  • 7. No robust argument.
    Prinz JC; Streit V
    Dtsch Arztebl Int; 2014 Jan; 111(3):35-6. PubMed ID: 24606782
    [No Abstract]   [Full Text] [Related]  

  • 8. Confirming the hypothesis at any cost?
    Nast A; Rzany B
    Dtsch Arztebl Int; 2014 Jan; 111(3):35. PubMed ID: 24606781
    [No Abstract]   [Full Text] [Related]  

  • 9. Information advantage or conflicts of interest?
    Kaufmann R
    Dtsch Arztebl Int; 2014 Jan; 111(3):36. PubMed ID: 24606783
    [No Abstract]   [Full Text] [Related]  

  • 10. [Publication ethics: regulation of financial conflicts of interests in medical journals].
    Kakuk P
    Lege Artis Med; 2011 Jan; 21(1):65-71. PubMed ID: 21469379
    [No Abstract]   [Full Text] [Related]  

  • 11. Accuracy in publishing: where does the responsibility lie?
    Cowell JM
    J Sch Nurs; 2011 Oct; 27(5):324-7. PubMed ID: 21989133
    [No Abstract]   [Full Text] [Related]  

  • 12. The sins of ghostwriting.
    Somberg JC
    Am J Ther; 2008; 15(4):297-8. PubMed ID: 18645328
    [No Abstract]   [Full Text] [Related]  

  • 13. 'Truth' in medical journal publishing.
    Ncayiyana DJ
    S Afr Med J; 2010 Jan; 100(2):71-2. PubMed ID: 20459898
    [No Abstract]   [Full Text] [Related]  

  • 14. Conflicts of interest, authorship, and disclosures in industry-related scientific publications.
    Baskin PK; Knopman DS; Gross RA
    Mayo Clin Proc; 2010 Feb; 85(2):196-7; author 201-4. PubMed ID: 20118396
    [No Abstract]   [Full Text] [Related]  

  • 15. Conflicts of interest in medicines safety and regulation: how much conflict and how much interest should we allow?
    Edwards IR
    Drug Saf; 2011 Aug; 34(8):617-21. PubMed ID: 21751823
    [No Abstract]   [Full Text] [Related]  

  • 16. The duty to disclose (even more) adverse clinical trial results.
    Hassoun N
    Am J Bioeth; 2009 Aug; 9(8):33-4. PubMed ID: 19998155
    [No Abstract]   [Full Text] [Related]  

  • 17. Respecting participant autonomy and the disclosure of clinical trial results.
    Oakley J
    Am J Bioeth; 2009 Aug; 9(8):38. PubMed ID: 19998158
    [No Abstract]   [Full Text] [Related]  

  • 18. Authorship policy.
    Novack GD
    Am J Ophthalmol; 2009 Jan; 147(1):184; author reply 184-5. PubMed ID: 19100357
    [No Abstract]   [Full Text] [Related]  

  • 19. Disclosure of adverse clinical trial results--should legal immunity be granted to drug companies?
    Vernillo A
    Am J Bioeth; 2009 Aug; 9(8):45-7. PubMed ID: 19998162
    [No Abstract]   [Full Text] [Related]  

  • 20. How to ensure our readers' trust: the proper attribution of authors and contributors.
    Liesegang TJ; Albert DM; Schachat AP
    Am J Ophthalmol; 2008 Sep; 146(3):337-40. PubMed ID: 18724976
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.